Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial

Table 4 Codetection of agents in multiplex real-time polymerase chain reaction assays from the same nasopharyngeal/oropharyngeal sample at initial visit of adults with ARTI^a by randomisation group (rapid result vs. delayed result)

Agent 1	Agent 2	C _t value^b (agent 1/agent 2)
Rapid result group
Rhinovirus	Influenza A virus	24/41
Rhinovirus	Respiratory syncytial virus	33/34
Rhinovirus	Mycoplasma pneumoniae	24/30
Mycoplasma pneumoniae	Rhinovirus	34/36
Mycoplasma pneumoniae	Coronavirus OC43	28/35
Adenovirus	Rhinovirus	20/35
Influenza B virus	Rhinovirus	36/38
Metapneumovirus	Rhinovirus	37/42
Parainfluenzavirus	Respiratory syncytial virus	28/30
Delayed result group
Influenza A virus	Coronavirus OC43	29/31
Influenza B virus	Rhinovirus	31/37
Respiratory syncytial virus	Rhinovirus	31/36

^aARTI, acute respiratory tract infection; ^b C _t value, cycle threshold value.